Introduction {#sec1-1}
============

Albumin is a protein produced in the liver which plays a role in blood oncotic pressure. Besides, in colloid osmotic pressure, albumin also works as a transport molecule for bilirubin, fatty acids, and medications \[[@ref1]\].

The role of albumin in critical illness is not fully understood. There are significant differences in the role of albumin between healthy and critically ill children. Low serum albumin concentrations in critically ill patients are associated with poor outcomes \[[@ref2]\], \[[@ref3]\], \[[@ref4]\]. In healthy individuals, albumin act to maintain Colloid Osmotic Pressure (COP) but is less correlated in critically ill individuals \[[@ref4]\]. Patient with a critical illness has a low COP. Among 200 patients, those with critical illness had a COP of 19.1 mmHg. Low colloid osmotic pressure correlates with high morbidity and mortality in critically ill patients. The COP of 15 mmHg is associated with a 50% life expectancy. Administration of albumin supplementation will increase COP and prevent fatal complications such as pulmonary oedema, which in turn, develop into respiratory failure \[[@ref3]\], \[[@ref4]\].

The osmotic pressure can be directly measured using oncometers or Van't Hoff equation: osmotic pressure = nx (c / M) x RT, where n = number of particles in the substrate (n = 1 for plasma proteins), c / M = molar concentration of the substrate, R = constant of 0.082, T = absolute temperature \[[@ref5]\].

Based on a descriptive study of 134 children with critical illness in the pediatric intensive care unit (PICU), the incidence of hypoalbuminemia before admission was 57% and may increase to 76% in the first 24 hours \[[@ref6]\].

Hypoalbuminemia often occurs in critical illness. The causes of hypoalbuminemia are complex and affected by various mechanisms such as the imbalance between albumin production and destruction, increased capillary permeability, and altered intravascular and extravascular albumin distribution \[[@ref2]\], \[[@ref4]\].

The relationship between hypoalbuminemia and poor outcomes has motivated clinicians to provide exogenous albumin in patients with hypoalbuminemia. Although hypoalbuminemia directly leads to a poor outcome, there is still controversy about this \[[@ref4]\].

Material and Methods {#sec1-2}
====================

This study used an observational method with a cross-sectional design. The study was conducted at Haji Adam Malik General Hospital from June 2008 to September 2008.

The subjects of the study were all patients admitted to PICU at Haji Adam Malik General Hospital, Medan, Indonesia, from the period of June 2008 to September 2008. The subjects were taken with the purposive sampling method.

The inclusion criteria included major post-operative surgery and critically ill, while the exclusion criteria included multiple congenital anomalies, post-operative surgery patient with length of stay less than 24 hours, burn patient and those who refuse to take part in the study.

The variables being studied include 1) albumin level in the first day admitted; 2) length of stay; 3) mortality; and 4) type of cases, with classification surgery or non-surgery case.

Before the research was carried out, ethical clearance was sought and approved by the Ethics Committee of Universitas Sumatera Utara Medical Faculty.

Results {#sec1-3}
=======

From this study, of 68 subjects in the PICU, there were 33 patients with hypoalbuminemia (48.5%) and 35 (51.4%) with normal albumin level. From the two groups, the mean albumin level was 3.05 g/dL (0.749), with the lowest levels of 1.5 g/dL and the highest at 4.7 g/dL. The mean albumin level was 2.33 g/dL in hypoalbuminemia group and 3.62 g/dL in normal albumin group with *P* = 0.001 ([Table 1](#T1){ref-type="table"}).

###### 

The characteristics of subjects in both study groups

  Parameter                         Hypoalbuminemia (n = 33)   Normal albumin (n = 35)
  --------------------------------- -------------------------- -------------------------
  Albumin level (g/dL), mean (SD)   2.33 (0.40)                3.61 (0.44)
  Gender, n (%)                                                
   Male                             23 (69.7)                  24 (68.6)
   Female                           10 (30.3)                  11 (31.4)
  Age (months)                      53.3                       53.1
  mean (SD)                         (49.9)                     (48.8)
  Weight (Kg)                       15.6                       14.8
  mean (SD)                         (13.13)                    (9.55)
  Eid index, n (%)                                             
   \< 70                            9 (27.3)                   11 (31.4)
   70-80                            3 (9.10)                   7 (20.0)
   80-90                            6 (18.2)                   7 (20.0)
   90-110                           10 (30.3)                  7 (20.0)
   110-120                          3 (9.10)                   2 (5.70)
   \> 120                           2 (6.10)                   1 (2.90)
  Type of cases, n (%)                                         
   Surgical                         21 (63.6)                  19 (54.3)
   Non-surgical                     12 (36.4)                  16 (45.7)

This study showed that there was a higher proportion of male than female. In the hypoalbuminemia group, the proportion of male patients was 69.7%, and female patients were 30.3%, whereas in the normal albumin group, the number of male patients was 68.6% and female patients were 31.4%.

Furthermore, the mean age, weight, and nutritional status, in this case, were assessed by EID index and type of case (surgical or non-surgical) between the two groups did not show significant differences.

In this study ([Table 2](#T2){ref-type="table"}), we also found that the hypoalbuminemia group needs longer treatment (7.6 days) compared to the normal albumin group (4.7 days).

###### 

The relationship between albumin levels and length of stay and mortality

  Parameter                          Hypo- albuminemia (n = 33)   Normal albumin (n = 35)   P
  ---------------------------------- ---------------------------- ------------------------- -------
  Length of stay (days); mean (SD)   7.6 (9.77)                   4.7 (5.0)                 0.134
  Mortality, n (%)                                                                          
   Yes                               12 (36.4)                    13 (37.1)                 0.947
   No                                21 (63.6)                    22 (62.9)                 

This is different from the results of this study where the patients were not distinguished whether as surgical and non-surgical cases, and it was found that there was higher mortality in the normal albumin group (37.1%) than the hypoalbuminemia group (36.4%) although both were not significantly different.

In this study ([Table 3](#T3){ref-type="table"} and [Table 4](#T4){ref-type="table"}), nutritional status had no significant association with length of stay and mortality, but the types of cases, whether surgical or non-surgical had a significant association with length of stay and mortality (*P* = 0.001). From [Table 3](#T3){ref-type="table"}, the results of multivariate analysis showed that the variables with the greatest contribution to the length of stay were the types of cases.

###### 

The results of multivariate analysis of length of stay

  Variable             B        P       95% CI
  -------------------- -------- ------- ----------------
  Albumin level        -3.502   0.049   -6.984; -0.020
  Type of cases        6.424    0.001   -2.838; 10.010
  Nutritional status   -0.146   0.808   -1.339; 1.047

###### 

The results of the multivariate analysis of mortality

  Variable             B        P       95% CI
  -------------------- -------- ------- --------------
  Albumin level        0.371    0.540   0.442; 4.775
  Type of cases        -2.093   0.001   0.038; 0.403
  Nutritional status            0.816   
   (1)                 -6.73    0.621   0.035; 7.338
   (2)                 -2.38    0.758   0.174; 3.578
   (3)                 -0.378   0.654   0.110; 3.577
   (4)                 0.677    0.450   0.340; 11.40
   (5)                 0.734    0.430   0.205; 3.511
   (6)                 2.331    0.322   0.123; 4.712

Discussion {#sec1-4}
==========

Albumin has several physiological functions and has been used extensively in the field of anaesthesia and intensive care as indicated. After more than 60 years of clinical research, administration of albumin is still questionable. In critically ill patients, several pathophysiological processes such as infection, trauma, or major surgery result in an inflammatory process that eventually releases mediators such as cytokines and leukocyte activation. This will result in disruption of endothelial function, increased microvascular permeability, and extravasation of fluid (including albumin) to the tissue. Acute-phase proteins, produced by the liver, are the sign of inflammation that is used to evaluate the relationship between hypoalbuminemia and poor outcomes \[[@ref7]\], \[[@ref8]\].

A prospective study of routine nutritional laboratory parameters examined less than 24 hours in 105 severely ill children in intensive care unit found a prevalence of hypomagnesaemia 20%, hypertriglyceridemia 25%, uremia 30%, and hypoalbuminemia 52% \[[@ref9]\].

Hypoalbuminemia is a marker of morbidity and mortality in children with a critical illness. A retrospective study comparing groups of patients with hypoalbuminemia and groups with normal albumin levels in patients in the PICU showed that in the hypoalbuminemia group, the length of stay in PICU was longer (8.1 days) compared to those with normal albumin levels (4.4 days). The hypoalbuminemia group has a lower life expectancy and a higher rate of organ failure \[[@ref10]\].

A study of cardiac and non-cardiac surgery patients and kidney impairment found that hypoalbuminemia was a predictor of poor outcome, where each 10 g/dL decrease in serum albumin would increase the mortality odds by 137%, morbidity by 89%, length of stay in the intensive care unit and hospital care by 28% and 71%, respectively \[[@ref11]\].

Hypoalbuminemia is the result of a combination of inflammation and inadequate caloric input in patients with chronic renal failure. Inflammation and malnutrition will reduce the synthesis and increase protein catabolism which may reduce albumin concentration \[[@ref12]\].

Transcapillary albumin excretion increased by 300% in patients with septic shock and by 100% after cardiac surgery. In septic patients, transcapillary changes will occur if appropriate treatment is administered. With increased albumin flow through the capillary membrane, there is an increase in lymphatic return to the intravascular space. Albumin movement during major surgery shows a decrease in lymphatic flow and albumin concentration in the lymphatic vessels. Measurements of total circulation and albumin exchange showed a 30% reduction with major surgery (Nicholson, 2000). In a prospective study, serum albumin was shown as a predictor of the outcome of postoperative patients \[[@ref13]\].

A Cochrane Collaboration study concluded that there is no evidence which showed that albumin reduces mortality in patients with hypovolemia compared to cheaper alternatives such as normal saline and in critically ill patients with burns or hypoalbuminemia \[[@ref14]\].

In this study, according to the intensive care unit protocol, all patients in the hypoalbuminemia group received albumin substitution as needed. Hypoalbuminemia is a frequent phenomenon in critical illness. Treatment focuses on the main causes of hypoalbuminemia rather than administering albumin. The results of several meta-analyses of albumin administration in hospitalised patients were inconsistent \[[@ref15]\].

The role of albumin in critically ill patients is not supported by scientific evidence. Hypoalbuminemia correction does not have a significant advantage; treatment is aimed at basic diseases to treat hypoalbuminemia \[[@ref13]\]. Albumin is recommended according to the appropriate indications for patients in the intensive care unit \[[@ref8]\].

Intravenous albumin is appropriate for patients with cirrhosis with ascites, kidney failure, and hepatorenal syndrome awaiting liver transplantation. In patients with nephrotic syndrome who do not respond to standard therapy, severe symptomatic hypovolemia, administration of intravenous albumin and diuretics might be considered \[[@ref16]\]. From an in-vitro study of sepsis patients, it was shown that albumin administration did not affect vascular permeability. The administration of 200 ml of 20% albumin was not significant in reducing microvascular protein leakage \[[@ref17]\]. From a review of a randomised clinical study, administering low dose hyperoncotic albumin for hypovolemic resuscitation has several advantages such as reducing morbidity, renal impairment, and oedema \[[@ref18]\].

Addition of albumin in parenteral nutrition solutions is also not recommended. It is said that fatal complications may occur compared to its benefits. Possible complications include infection, incompatibility, and chemical and physical instability \[[@ref19]\]. It was stated that the administration of albumin would cause a decrease in life expectancy in patients with critical illness \[[@ref20]\]. This is in contrast to a study of a meta-analysis of randomised controlled trials that did not find the effect of albumin on mortality \[[@ref21]\].

The study also found no difference between the hypoalbuminemia and normal albumin groups to mortality (P = 0.947). Based on previous studies and based on the results of our study, albumin levels do not affect the length of stay and mortality of patients in the intensive care unit.

In this study, there was no effect of albumin levels on the length of stay and mortality of patients in the pediatric intensive care unit. The type of cases has a significant association in the length of stay and mortality.
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